This joint course organised by the International Agency for Atomic Energy (IAEA), the Jules Bordet Institute and BELNUC will offer a comprehensive view on the use of theranostics and radionuclide therapy anno 2017.
This course aims to provide basic and in-depth state-of-the art insight on current image-based radionuclide therapy strategies in the clinic and emerging radiopharmaceuticals.
The primary public are all clinicians and scientists interested in theranostic imaging and radionuclide therapy: nuclear medicine physicians, oncologists, internists, radiation oncologists, physicists/engineers, radiochemists/-pharmacists, technologists and others.
A selected faculty of renowed national and international speakers are a guarantee for high quality lectures.
Different radionuclide treatments are discussed on specific days.
